Health
Results: 1261-1272 of 7444

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy

Bioretec Ltd's Half-year report 2025: Strong support for future growth from a successful rights issue

Results: 1261-1272 of 7444


